Alcon AG | ALC - Dochód Netto





Dochód Netto Zmiana Data
AstraZeneca USD 3.08B 754M 2026-03
Bayer EUR 2.76B 6.52B 2026-03
Essilor EUR 928M 459M 2025-12
Fresenius EUR 361M 17M 2025-12
Fresenius Medical Care EUR 118M 209M 2026-03
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
GRIFOLS EUR 73M 25.25M 2026-03
Lonza CHF 426M 119M 2025-06
Merck EUR 659M 340M 2026-03
Novartis USD 3.16B 747M 2026-03
Philips EUR 151M 244M 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR 1.61B 2.42B 2026-03
Smith & Nephew USD 293M 79M 2025-12
Sonova Holding CHF 188.5M 143.4M 2025-12
UCB EUR 1.08B 608M 2025-12